Ignite Creation Date:
2024-07-17 @ 11:07 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06470477
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-24
First Post:
2022-11-14
Brief Title:
Molecular Characteristics of Phlegm-heat Syndrome in Ischemic Stroke
Sponsor:
Dongzhimen Hospital Beijing
Organization:
Dongzhimen Hospital Beijing
Study Overview
Official Title:
Molecular Characteristics of Phlegm-heat Syndrome in Ischemic Stroke A Cohort Study
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The molecular characteristics of ischemic stroke with phlegm-heat syndrome and candidate biomarkers were identified based on multi-omics data The main purpose of this study is to validate the molecular characteristics and biomarkers of phlegm-heat syndrome in ischemic stroke and to demonstrate the association of biomarkers with clinical outcomes
Detailed Description:
This is a cohort study in patients with acute ischemic stroke The demographic characteristics Traditional Chinese Medicine TCM syndromes and other baseline information will be recorded At the same time baseline peripheral blood will be collected These participants will be followed up to 90 days of onset and 90-day modified Rankin scale mRS scores will be assessed The collected blood samples will be tested by multi-factor detection technology for candidate biomarkers
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None